These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
350 related articles for article (PubMed ID: 18166587)
1. Secretory IgA mediates retrotranscytosis of intact gliadin peptides via the transferrin receptor in celiac disease. Matysiak-Budnik T; Moura IC; Arcos-Fajardo M; Lebreton C; Ménard S; Candalh C; Ben-Khalifa K; Dugave C; Tamouza H; van Niel G; Bouhnik Y; Lamarque D; Chaussade S; Malamut G; Cellier C; Cerf-Bensussan N; Monteiro RC; Heyman M J Exp Med; 2008 Jan; 205(1):143-54. PubMed ID: 18166587 [TBL] [Abstract][Full Text] [Related]
2. Pathways of gliadin transport in celiac disease. Heyman M; Menard S Ann N Y Acad Sci; 2009 May; 1165():274-8. PubMed ID: 19538316 [TBL] [Abstract][Full Text] [Related]
3. Interactions among secretory immunoglobulin A, CD71, and transglutaminase-2 affect permeability of intestinal epithelial cells to gliadin peptides. Lebreton C; Ménard S; Abed J; Moura IC; Coppo R; Dugave C; Monteiro RC; Fricot A; Traore MG; Griffin M; Cellier C; Malamut G; Cerf-Bensussan N; Heyman M Gastroenterology; 2012 Sep; 143(3):698-707.e4. PubMed ID: 22750506 [TBL] [Abstract][Full Text] [Related]
4. Gluten induces coeliac-like disease in sensitised mice involving IgA, CD71 and transglutaminase 2 interactions that are prevented by probiotics. Papista C; Gerakopoulos V; Kourelis A; Sounidaki M; Kontana A; Berthelot L; Moura IC; Monteiro RC; Yiangou M Lab Invest; 2012 Apr; 92(4):625-35. PubMed ID: 22330344 [TBL] [Abstract][Full Text] [Related]
5. Deficient activity of mammalian prolyl oligopeptidase on the immunoactive peptide digestion in coeliac disease. Garcia-Horsman JA; Venäläinen JI; Lohi O; Auriola IS; Korponay-Szabo IR; Kaukinen K; Mäki M; Männistö PT Scand J Gastroenterol; 2007 May; 42(5):562-71. PubMed ID: 17454876 [TBL] [Abstract][Full Text] [Related]
6. Limited efficiency of prolyl-endopeptidase in the detoxification of gliadin peptides in celiac disease. Matysiak-Budnik T; Candalh C; Cellier C; Dugave C; Namane A; Vidal-Martinez T; Cerf-Bensussan N; Heyman M Gastroenterology; 2005 Sep; 129(3):786-96. PubMed ID: 16143118 [TBL] [Abstract][Full Text] [Related]
7. Paracellular versus transcellular intestinal permeability to gliadin peptides in active celiac disease. Ménard S; Lebreton C; Schumann M; Matysiak-Budnik T; Dugave C; Bouhnik Y; Malamut G; Cellier C; Allez M; Crenn P; Schulzke JD; Cerf-Bensussan N; Heyman M Am J Pathol; 2012 Feb; 180(2):608-15. PubMed ID: 22119716 [TBL] [Abstract][Full Text] [Related]
8. Intestinal permeability in coeliac disease: insight into mechanisms and relevance to pathogenesis. Heyman M; Abed J; Lebreton C; Cerf-Bensussan N Gut; 2012 Sep; 61(9):1355-64. PubMed ID: 21890812 [TBL] [Abstract][Full Text] [Related]
9. Role of IgA receptors in the pathogenesis of IgA nephropathy. Lechner SM; Papista C; Chemouny JM; Berthelot L; Monteiro RC J Nephrol; 2016 Feb; 29(1):5-11. PubMed ID: 26572664 [TBL] [Abstract][Full Text] [Related]
10. Targeting of gliadin peptides, CD8, alpha/beta-TCR, and gamma/delta-TCR to Golgi complexes and vacuoles within celiac disease enterocytes. Zimmer KP; Naim H; Weber P; Ellis HJ; Ciclitira PJ FASEB J; 1998 Oct; 12(13):1349-57. PubMed ID: 9761778 [TBL] [Abstract][Full Text] [Related]
11. Food antigens and Transglutaminase 2 in IgA nephropathy: Molecular links between gut and kidney. Abbad L; Monteiro RC; Berthelot L Mol Immunol; 2020 May; 121():1-6. PubMed ID: 32135400 [TBL] [Abstract][Full Text] [Related]
12. Identification of a peptide from alpha-gliadin resistant to digestive enzymes: implications for celiac disease. Mamone G; Ferranti P; Rossi M; Roepstorff P; Fierro O; Malorni A; Addeo F J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Aug; 855(2):236-41. PubMed ID: 17544966 [TBL] [Abstract][Full Text] [Related]
13. [Pathogenesis of Berger's disease: recent advances on the involvement of immunoglobulin A and their receptors]. Monteiro RC; Leroy V; Launay P; Moura IC; Arcos-Fajardo M; Benhamou M; Haddad E Med Sci (Paris); 2003 Dec; 19(12):1233-41. PubMed ID: 14691748 [TBL] [Abstract][Full Text] [Related]
14. Antagonist peptides of the gliadin T-cell stimulatory sequences: a therapeutic strategy for celiac disease. Silano M; Vincentini O; Iapello A; Mancini E; De Vincenzi M J Clin Gastroenterol; 2008 Sep; 42 Suppl 3 Pt 2():S191-2. PubMed ID: 18685513 [TBL] [Abstract][Full Text] [Related]
15. Resistance to celiac disease in humanized HLA-DR3-DQ2-transgenic mice expressing specific anti-gliadin CD4+ T cells. de Kauwe AL; Chen Z; Anderson RP; Keech CL; Price JD; Wijburg O; Jackson DC; Ladhams J; Allison J; McCluskey J J Immunol; 2009 Jun; 182(12):7440-50. PubMed ID: 19494267 [TBL] [Abstract][Full Text] [Related]
16. A quantitative analysis of transglutaminase 2-mediated deamidation of gluten peptides: implications for the T-cell response in celiac disease. Dørum S; Qiao SW; Sollid LM; Fleckenstein B J Proteome Res; 2009 Apr; 8(4):1748-55. PubMed ID: 19239248 [TBL] [Abstract][Full Text] [Related]
17. Epithelial transport of immunogenic and toxic gliadin peptides in vitro. Zimmermann C; Rudloff S; Lochnit G; Arampatzi S; Maison W; Zimmer KP PLoS One; 2014; 9(11):e113932. PubMed ID: 25415429 [TBL] [Abstract][Full Text] [Related]
18. Interaction of 'toxic' and 'immunogenic' A-gliadin peptides with a membrane-mimetic environment. Vilasi S; Sirangelo I; Irace G; Caputo I; Barone MV; Esposito C; Ragone R J Mol Recognit; 2010; 23(3):322-8. PubMed ID: 19771572 [TBL] [Abstract][Full Text] [Related]
19. Adaptive and innate immune responses in celiac disease. Gianfrani C; Auricchio S; Troncone R Immunol Lett; 2005 Jul; 99(2):141-5. PubMed ID: 15876458 [TBL] [Abstract][Full Text] [Related]
20. Enterocyte proliferation and signaling are constitutively altered in celiac disease. Nanayakkara M; Lania G; Maglio M; Kosova R; Sarno M; Gaito A; Discepolo V; Troncone R; Auricchio S; Auricchio R; Barone MV PLoS One; 2013; 8(10):e76006. PubMed ID: 24204586 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]